CTAP

CTAP is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. CTAP displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction.
Read more
€0.00 (tax incl.)
Reference:
HY-P1335
Product Details
HY-P1335

Data sheet

Size
Multiple sizes
Reactivity
Opioid Receptor
Application
Neuroscience-Neuromodulation
CAS
103429-32-9

Menu

Settings